scholarly article | Q13442814 |
P50 | author | John M. Davis | Q57081275 |
Cynthia S Crowson | Q87215892 | ||
Véronique L. Roger | Q110955107 | ||
P2093 | author name string | Terry M Therneau | |
Sherine E Gabriel | |||
Hilal Maradit-Kremers | |||
Elena Myasoedova | |||
Paulo J Nicola | |||
P2860 | cites work | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 |
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years | Q24674079 | ||
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis | Q24812557 | ||
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
Diagnosis and classification of diabetes mellitus | Q28299875 | ||
Report of the expert committee on the diagnosis and classification of diabetes mellitus | Q34167177 | ||
Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases | Q34359522 | ||
History of the Rochester Epidemiology Project | Q34374377 | ||
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register | Q34395284 | ||
Mechanisms and models in heart failure: the biomechanical model and beyond | Q34422770 | ||
Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease | Q35549143 | ||
Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis | Q35638288 | ||
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis | Q35638369 | ||
Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy | Q35676074 | ||
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study | Q35941063 | ||
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
Role of inflammation in the progression of heart failure | Q36806972 | ||
The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. | Q37074034 | ||
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute | Q37417065 | ||
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37640953 | ||
The epidemiology of heart failure: the Framingham Study | Q38512101 | ||
Classification of heart failure in population based research: an assessment of six heart failure scores | Q43814913 | ||
Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study | Q43876632 | ||
Natural history of asymptomatic left ventricular systolic dysfunction in the community | Q43884752 | ||
Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis | Q45129989 | ||
How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? | Q46732422 | ||
Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. | Q51773790 | ||
The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 | ||
International diagnostic criteria for acute myocardial infarction and acute stroke | Q71379325 | ||
Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults | Q77367158 | ||
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association | Q77701974 | ||
Extra-articular rheumatoid arthritis: prevalence and mortality | Q78169221 | ||
Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study | Q80401292 | ||
Diastolic function abnormalities in rheumatoid arthritis: relation with duration of disease | Q80407291 | ||
Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? | Q80800883 | ||
The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease | Q81285682 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart failure | Q181754 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 1601-1606 | |
P577 | publication date | 2011-05-15 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | The influence of rheumatoid arthritis disease characteristics on heart failure | |
P478 | volume | 38 |
Q30940911 | A novel measure of socioeconomic status using individual housing data to assess the association of SES with rheumatoid arthritis and its mortality: a population-based case-control study. |
Q52587395 | Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. |
Q87035377 | Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis |
Q38876331 | Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment. |
Q33582869 | Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. |
Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
Q38757421 | Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force |
Q34092449 | Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register. |
Q93148453 | Early short-term ivabradine treatment in new-onset acute systolic heart failure and sinus tachycardia patients with inflammatory rheumatic disease |
Q35210847 | Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis |
Q57308303 | Epidemiology of heart failure with preserved ejection fraction |
Q38098647 | Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. |
Q40379963 | Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study |
Q51835838 | Immune-Mediated Heart Disease. |
Q37209902 | Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study |
Q33595578 | Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study |
Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
Q41150203 | Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. |
Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
Q34157718 | Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study |
Q33695937 | Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers |
Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
Q35994802 | Preventing Heart Failure in Inflammatory and Immune Disorders |
Q47095887 | Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study |
Q38608511 | Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis |
Q28709376 | Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis |
Q24630655 | Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity |
Q34810005 | Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study |
Q38648390 | Risk of Obstructive Sleep Apnea and Its Association with Cardiovascular and Noncardiac Vascular Risk in Patients with Rheumatoid Arthritis: A Population-based Study |
Q92771595 | Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment |
Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
Q36240514 | The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing? |
Q38091933 | The role of B-cells in heart failure |
Q35904678 | The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease |
Q85589116 | [Risk of atherosclerosis mediated by inflammation in rheumatoid arthritis] |
Search more.